| 1 | 2924-02-9 | Thiocyanic acid, 4-fluorophenyl ester | C7H4FNS | 153.18 | | |
| 2 | 2924-05-2 | 2,7-Dithiatricyclo[6.2.0.03,6]deca-3(6),8(1)-diene, 4,4,5,5,9,9,10,10-octafluoro- | C8F8S2 | 312.2 | | |
| 3 | 2924-09-6 | 5-Bromo-2-fluoroaniline | C6H5BrFN | 190.01 | 27℃ | Slightly soluble in water. |
| 4 | 2924-15-4 | 2-Fluorophenylhydrazine hydrochloride | C6H8ClFN2 | 162.59 | 200-205°C (dec.)(lit.) | |
| 5 | 2924-16-5 | 3-Fluorophenylhydrazine hydrochloride | C6H8ClFN2 | 162.59 | 268°C (dec.)(lit.) | |
| 6 | 2924-25-6 | 1-(1-propenyl)-3-(trifluoromethyl)benzene | C10H9F3 | 186.17 | | |
| 7 | 2924-26-7 | Ethanone, 2,2,2-trifluoro-1-(2-hydroxy-4,5-dimethoxyphenyl)- | C10H9F3O4 | 250.17 | | |
| 8 | 2924-28-9 | Mercury, chloro(2-fluorophenyl)- | C6H4ClFHg | 331.137 | | |
| 9 | 2924-29-0 | 2H,2H-Perfluorobutane | C4H2F8 | 202.05 | | |
| 10 | 2924-30-3 | 2,4-Dibromo-3-fluoro-6-nitrophenol | C6H2Br2FNO3 | 314.89 | | |
| 11 | 2924-31-4 | Butane, 2-bromo-1,1,1,2,3,4,4,4-octafluoro- | C4HBrF8 | 280.94 | | |
| 12 | 2924-34-7 | β-D-Ribofuranosyl fluoride, 2,3,5-tribenzoate | C26H21FO7 | 464.44 | | |
| 13 | 2924-46-1 | Haloperidine | C26H30ClFN2O2 | 456.98 | | |
| 14 | 2924-61-0 | Pyrimidine, 2,4-bis(1-aziridinyl)-5-fluoro- | C8H9FN4 | 180.18 | | |
| 15 | 2924-64-3 | Resorcinol, 4-fluoro-2,6-dimethyl- (7CI,8CI) | C8H9FO2 | | | |
| 16 | 2924-65-4 | 2-(2-Fluoro-phenoxy)-ethanol | C8H9FO2 | 156.15 | | |
| 17 | 2924-66-5 | 2-(4-Fluorophenoxy)ethanol | C8H9O2F | 156.15 | | |
| 18 | 2924-67-6 | fluoresone | C8H9FO2S | 188.22 | | |
| 19 | 2924-72-3 | Ethyl p-fluorobenzenesulfonate | C8H9FO3S | 204.22 | | |
| 20 | 2924-77-8 | (4-TRIFLUOROMETHYL-BENZYL)-HYDRAZINE | C8H9F3N2 | 190.17 | | |
| 21 | 2924-79-0 | 4(3H)-Pyrimidinone, 6-(dimethoxymethyl)-2-(trifluoromethyl)- | C8H9F3N2O3 | 238.16 | | |
| 22 | 2924-82-5 | ETHYL 4-HYDRAZINO-2-(TRIFLUOROMETHYL)PYRIMIDINE-5-CARBOXYLATE | C8H9F3N4O2 | 250.18 | | |
| 23 | 2924-95-0 | N-(4-TRIFLUOROMETHYLPHENYL)PROPIONAMIDE | C10H10F3NO | 217.19 | | |
| 24 | 29240-17-3 | tert-Amyl perpivalate | C10H20O3 | 188.26 | | 504mg/L at 20℃ |
| 25 | 29240-30-0 | p-Toluic acid isobutyl ester | C12H16O2 | 192.25 | | |
| 26 | 29240-33-3 | Benzoic acid, 4-cyano-, 1-Methylethyl ester | C11H11NO2 | 189.21 | | |
| 27 | 29240-44-6 | Benzeneethanol, β-bromo-α,α-diphenyl- | C20H17BrO | 353.25 | | |
| 28 | 29240-62-8 | 4-Quinolinecarboxylicacid, 6,8-dichloro-2-(3-iodophenyl)- | C16H8Cl2INO2 | 444.05069 | | |
| 29 | 29240-68-4 | Ethanone,2-bromo-1-[6,8-dichloro-2-(3-iodophenyl)-4-quinolinyl]- | C17H9BrCl2INO | 520.97393 | | |
| 30 | 2924000-19-9 | (2S)-2-Amino-N-[4-[2-(Boc-amino)-1-hydroxyethyl]phenyl]propanamide | | | | |
| 31 | 2924006-98-2 | 3H-Pyrazolo[3,4-d]pyrimidin-3-one, 1,2-dihydro-6-[[4-(4-methyl-1-piperazinyl)phenyl]amino]-2-(2-propen-1-yl)-1-[6-(2-pyrazinyl)-2-pyridinyl]- | C28H28N10O | 520.59 | | |
| 32 | 2924020-81-3 | tert-Butyl 3-formyl-5,7-dihydro-6H-pyrrolo[3,4-b]pyridine-6-carboxylate | | | | |
| 33 | 2924021-45-2 | tert-butyl (9aR)-9-oxo-octahydro-1H-[1,4]diazino[1,2-a]pyrazine-2-carboxylate | C12H21N3O3 | 255.31 | | |
| 34 | 2924036-87-1 | SHP2/CDK4-IN-1 | C33H35ClF2N10OS | 693.21 | | |
| 35 | 2924055-46-7 | CamA-IN-1 | C23H36N6O6 | 492.57 | | |
| 36 | 2924063-70-5 | GPR183-IN-1 | C16H19BrN2O2 | 351.24 | | |
| 37 | 2924063-98-7 | GPR183 antagonist-2 | C20H18F2N4O5 | 432.38 | | |
| 38 | 2924064-10-6 | GPR183-IN-2 | C19H23BrN2O3 | 407.3 | | |
| 39 | 2924065-12-1 | SHP2-IN-34 | | | | |
| 40 | 2924092-57-7 | 2,6-Piperidinedione, 3-[2,6-difluoro-4-(3-hydroxy-1-azetidinyl)phenyl]- | C14H14F2N2O3 | 296.27 | | |
| 41 | 2924092-66-8 | 3-(4-Bromo-2-fluorophenyl)piperidine-2,6-dione | C11H9BrFNO2 | 286.1 | | |
| 42 | 2924092-72-6 | 3-(4-Bromo-2-chloro-5-fluorophenyl)piperidine-2,6-dione | C11H8BrClFNO2 | 320.54 | | |
| 43 | 2924098-58-6 | Tadalafil Impuirty 20 | | | | |
| 44 | 29241-15-4 | 1,2,3-Benzothiadiazole, 5-chloro- | C6H3ClN2S | 170.62 | | |
| 45 | 29241-16-5 | 6-nitrobenzo[d][1,2,3]thiadiazole | C6H3N3O2S | 181.17 | | |
| 46 | 29241-60-9 | 5-Bromo-2-chloro-3-picoline | C6H5BrClN | 206.47 | 40-44 °C | |
| 47 | 29241-62-1 | 5-Bromo-6-chloronicotinic acid | C6H3BrClNO2 | 236.45 | 166-168°C | |
| 48 | 29241-63-2 | 5-bromo-6-fluoro-pyridine-3-carboxylic acid | C6H3BrFNO2 | 220 | | |
| 49 | 29241-64-3 | 5,6-dibromopyridine-3-carboxylic acid | C6H3Br2NO2 | 280.9 | | |
| 50 | 29241-65-3 | 5,6-DibromonicotinicAcid | | | | |
| 51 | 29241-65-4 | 5-Bromo-2-chloronicotinic acid | C6H3BrClNO2 | 236.45 | 173-176°C | |
| 52 | 29241-66-5 | 5-Bromo-2-fluoronicotinic acid | C6H3BrFNO2 | 220 | | |
| 53 | 29241-85-8 | 3(4H)-Isoquinolinone, 1-(hydroxyamino)- | C9H8N2O2 | 176.17 | | |
| 54 | 2924103-17-1 | Benzamide, 3-bromo-5-(2-bromoacetyl)-2-hydroxy- | C9H7Br2NO3 | 336.96 | | |
| 55 | 2924115-64-8 | Cadapersen | | | | |
| 56 | 2924118-10-3 | Bedaquiline Impurity | | | | |
| 57 | 2924118-12-5 | (3S,4R)-4-(6-Bromo-2-methoxyquinolin-3-yl)-3-hydroxy-N,N-dimethyl-3-(naphthalen-1-yl)-4-phenylbutan-1-amine oxide (Bedaquiline Impurity) | C32H31BrN2O3 | 571.5 | | |
| 58 | 2924122-01-8 | NA | C23H26ClN3O5 | 459.92 | | |
| 59 | 2924122-72-3 | 3-[6-(aminomethyl)-5-fluoro-1-oxo-2,3-dihydro-1H-isoindol-2-yl]hexahydropyridine-2,6-dione hydrochloride | C14H14FN3O3.ClH | 327.74 | | |
| 60 | 2924154-78-7 | Ethyl 4-bromo-3-fluoro-1H-pyrazole-5-carboxylate | | | | |
| 61 | 2924156-46-5 | Anti-inflammatory agent 54 | C17H16N2O5 | 328.32 | | |
| 62 | 2924156-51-2 | Anti-inflammatory agent 55 | | | | |
| 63 | 2924156-96-5 | 4(1H)-Quinazolinone, 2,3-dihydro-2-(1H-indol-5-yl)- | C16H13N3O | 263.29 | | |
| 64 | 2924181-60-0 | PHD2-IN-4 | | | | |
| 65 | 2924181-77-9 | PHD-IN-3 | C20H18N6O3 | 390.4 | | |
| 66 | 2924182-31-8 | PHD-IN-1 | | 441.49 | | |
| 67 | 2924182-42-1 | PHD-IN-2 | | 501.54 | | |
| 68 | 2924193-12-2 | CDK8-IN-14 | C18H13N3O2 | 303.32 | | |
| 69 | 2924193-31-5 | Pemafibrate-d4 | | | | |
| 70 | 2924199-92-6 | m-PEG37-acid | C76H152O39 | 1690 | | |
| 71 | 29242-09-9 | Hexadecanoic acid, 9,10-dihydroxy- | C16H32O4 | 288.42 | | |
| 72 | 29242-15-7 | 9H-Xanthen-9-one,4-[(dimethylamino)methyl]-, hydrochloride (1:1) | C16H16ClNO2 | 289.75674 | | |
| 73 | 29242-17-9 | Xanthen-9-one, 4-(diethylamino)methyl-, hydrochloride | | | | |
| 74 | 29242-22-6 | 9H-Xanthen-9-one,4-(4-morpholinylmethyl)-, hydrochloride (1:1) | C18H18ClNO3 | 331.79342 | | |
| 75 | 29242-23-7 | Benzenebutanoic acid, α-hydroxy-α,2-dimethyl-γ-oxo- | C12H14O4 | 222.24 | | |
| 76 | 29242-28-2 | Benzenebutanoic acid, 4-chloro-α-hydroxy-α-methyl-γ-oxo- | C11H11ClO4 | 242.66 | | |
| 77 | 29242-35-1 | 29242-35-1 | C12H14O5 | 238.24 | | |
| 78 | 29242-37-3 | 3(2H)-Pyridazinone, 4-methyl-6-(2-methylphenyl)-2-[2-(4-morpholinyl)ethyl]-, hydrochloride (1:1) | C18H24ClN3O2 | 349.86 | | |
| 79 | 29242-38-4 | 3(2H)-Pyridazinone, 4-methyl-6-(3-methylphenyl)-2-[2-(4-morpholinyl)ethyl]-, hydrochloride (1:1) | C18H24ClN3O2 | 349.86 | | |
| 80 | 29242-40-8 | 6-(o-Chlorophenyl)-4-methyl-2-(2-morpholinoethyl)-3(2H)-pyridazinone h ydrochloride | | | | |
| 81 | 29242-43-1 | 3(2H)-Pyridazinone, 6-(4-chlorophenyl)-2-[2-(dimethylamino)ethyl]-4-methyl-, hydrochloride (1:1) | C15H19Cl2N3O | 328.24 | | |
| 82 | 29242-84-0 | 2-Chloro-4-methoxyaniline | C7H8ClNO | 157.6 | 114℃ | |
| 83 | 29242-87-3 | 2,4-Dichloro-1-naphtylamine | C10H7Cl2N | 212.08 | 80 °C | |
| 84 | 2924224-42-8 | Finerenone impurity 34 | | | | |
| 85 | 2924274-19-9 | TJ08 | | | | |
| 86 | 29243-26-3 | bis(p-anilinophenyl)[4-[(3-methylphenyl)amino]phenyl]methylium sulphate (2:1) | C76H64N6O4S | 1157.42416 | | |
| 87 | 29243-46-7 | magnesium 4-[(dipropylamino)sulphonyl]benzoate | C26H36MgN2O8S2 | 593.00764 | | |
| 88 | 29243-71-8 | 3-(2-furylacryloyl)glycine | C9H9NO4 | 195.17 | | |
| 89 | 29243-80-9 | (+-)-2,5-DIMETHOXY-4-METHYLAMPHETAMINE*H YDROCHLORID | | | | |
| 90 | 29243-99-0 | Oxiraneoctanoic acid, 3-hexyl-, cis- (9CI) | C16H30O3 | 270.41 | | |
| 91 | 2924344-29-4 | TRK-IN-23 | C20H17FN4O2 | 364.37 | | |
| 92 | 29244-39-1 | 1,11-Ethano-5H,7H-dibenz[b,g][1,5]oxathiocin | C16H14OS | 254.3 | | |
| 93 | 29244-55-1 | 1-(4-Methylphenyl)-3,4-dichloro-3-pyrroline-2,5-dione | C11H7Cl2NO2 | 256.08 | | |
| 94 | 29244-58-4 | 1H-Pyrrole-2,5-dione,1,1'-(1,6-hexanediyl)bis[3,4-dichloro- | C14H12Cl4N2O4 | 414.06808 | | |
| 95 | 2924403-17-6 | PD-1/PD-L1-IN-34 | | | | |
| 96 | 2924415-92-7 | Ack1 inhibitor 1 | C39H40F3N7O4 | 727.78 | | |
| 97 | 2924425-63-6 | PB131 | C16H16FN3O2 | 301.32 | | |
| 98 | 2924450-63-3 | RXFP1 receptor agonist-10 | | | | |
| 99 | 2924460-54-6 | RXFP1 receptor agonist-2 | C33H32F7N3O5 | 683.61 | | |
| 100 | 2924460-80-8 | TYK2 ligand 2 | | | | |
| 101 | 2924461-92-5 | 2-(20-hydroxy-3,6,9,12,15,18-hexaoxaicosyl)isoindoline-1,3-dione | | | | |
| 102 | 2924480-17-9 | Fmoc-N-amido-PEG5-azide | C27H36N4O7 | 528.6 | | |
| 103 | 2924483-23-6 | Ombuin 3-O-rhamnoside | C23H24O11 | 476.43 | | |
| 104 | 2924484-79-5 | (S)-OY-101 | | | | |
| 105 | 2924486-45-1 | Rac1-IN-4 | C23H16ClN5O2 | 429.86 | | |
| 106 | 29245-44-1 | 5-bromo-2-(5-bromo-4-chloro-1,3-dihydro-3-oxo-2H-indol-2-ylidene)-4-chloro-1,2-dihydro-3H-indol-3-one | C16H6Br2Cl2N2O2 | 488.95 | | |
| 107 | 29245-61-2 | Sulfonium, triethyl- | C6H15S+ | 119.25 | | |
| 108 | 29245-72-5 | Methyldithio (8CI,9CI) | CH3S2* | 79.16452 | | |
| 109 | 29245-93-0 | Ethanamine, 2-[2-(ethylthio)ethoxy]- | C6H15NOS | 149.25 | | |
| 110 | 2924532-47-6 | Anticancer agent 121 | | | | |
| 111 | 2924532-50-1 | Anticancer agent 122 | C18H15ClN2O2S | 358.84 | | |
| 112 | 2924546-70-1 | SJ1461 | C21H18ClN7OS2 | 484 | | |
| 113 | 2924547-57-7 | NLRP3-IN-77 | | | | |
| 114 | 2924557-38-8 | Ethanone, 2-[4-[4-(4-isoquinolinyl)phenyl]-1H-pyrazol-1-yl]-1-(1-piperazinyl)- | C24H23N5O | 397.47 | | |
| 115 | 2924557-42-4 | SNX7886 | C52H59N9O7 | 922.08 | | |
| 116 | 2924558-68-7 | 5-(4-Fluoro-1H-indazol-5-yl)pyridin-2-amine | C12H9FN4 | 228.23 | | |
| 117 | 2924565-59-1 | NF-κB-IN-8 | C24H21N3O3 | 399.44 | | |
| 118 | 2924573-90-8 | FX-909 | | | | |
| 119 | 2924598-24-1 | BETA-1 | | | | |
| 120 | 29246-20-6 | 2,7-Benzodioxecin-1,8-dione,3,4,5,6-tetrahydro-(9CI) | C12H12O4 | 220.22 | | |
| 121 | 29246-34-2 | 10-Undecenamide, N-phenyl- | C17H25NO | 259.39 | | |
| 122 | 29246-35-3 | N-(3-chlorophenyl)-10-undecenamide | C17H24ClNO | 293.83156 | | |
| 123 | 29246-36-4 | 10-Undecenamide, N-(4-chlorophenyl)- | C17H24ClNO | 293.83 | | |
| 124 | 29246-70-6 | 4-Nitro-trans-cinnamonitrile | C9H6N2O2 | 174.16 | | |
| 125 | 29246-75-1 | 3-Nonenenitrile | | | | |
| 126 | 29246-76-2 | 3-Hexenenitrile, 5-methyl- | C7H11N | 109.17 | | |
| 127 | 29246-94-4 | Benzeneacetic acid, α-?hydroxy-?α-?(trifluoromethyl)?-?, (αS)?- | C9H7F3O3 | 220.15 | | |
| 128 | 29246-97-7 | 4'-dodecyl-3-hydroxynaphth-2-anilide | C29H37NO2 | 431.61 | | |
| 129 | 2924606-55-1 | Lipid N2-3L | C48H93N3O8 | 840.27 | | |
| 130 | 2924619-64-5 | RXFP1 receptor agonist-1 | | | | |
| 131 | 2924694-52-8 | 3(2H)-Pyridazinone, 6-chloro-2-[(4-methoxyphenyl)methyl]-4-methyl- | C13H13ClN2O2 | 264.71 | | |
| 132 | 29247-15-2 | 3-(4-Benzyloxyphenoxy)-2-hydroxypropanamine | C16H19NO3 | 273.33 | | |
| 133 | 29247-71-0 | Benzoic acid,2-[(2-chloro-2-propen-1-yl)[(4-methylphenyl)sulfonyl]amino]- | C17H16ClNO4S | 365.83124 | | |
| 134 | 29247-78-7 | Benzoic acid, 2-[(2-chloro-2-propen-1-yl)amino]-, methyl ester | C11H12ClNO2 | 225.67 | | |
| 135 | 29247-79-8 | Benzoic acid, 4-chloro-2-[[(4-methylphenyl)sulfonyl]amino]-, methyl ester | C15H14ClNO4S | 339.79 | | |
| 136 | 29247-82-3 | 3H-1-Benzazepin-3-one,8-chloro-1,2,4,5-tetrahydro-1-[(4-methylphenyl)sulfonyl]- | C17H16ClNO3S | 349.83 | | |
| 137 | 29247-87-8 | 2-iodoisonicotinic acid hydrazide | | | | |
| 138 | 2924710-37-0 | 2-Methyl-4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-2,4-dihydro-3H-1,2,4-triazol-3-one | | | | |
| 139 | 2924710-55-2 | Ozanimod Impurity 3 | C12H16N2O2 | 220.27 | | |
| 140 | 2924751-56-2 | (2-Bromo-4-nitrophenyl)(4,4-difluoro-1-piperidyl)methanone | | | | |
| 141 | 2924752-26-9 | 1H-Pyrazole, 1-(3-oxetanyl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)- | C12H19BN2O3 | 250.1 | | |
| 142 | 2924754-60-7 | Cyclophosphamide impurity 30 | | | | |
| 143 | 2924757-05-9 | Fedratinib Impurity 20 | | | | |
| 144 | 2924760-04-1 | 1-Piperidinecarboxylic acid, 3-(1,3-dihydro-5-hydroxy-1,3-dioxo-2H-isoindol-2-yl)-2,6-dioxo-, 1,1-dimethylethyl ester | C18H18N2O7 | 374.35 | | |
| 145 | 2924760-07-4 | (2S,4R)-1-((S)-3,3-Dimethyl-2-(oct-7-ynamido)butanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide | C30H40N4O4S | 552.73 | | |
| 146 | 2924764-21-4 | CDP-771|||CMA-676 | | | | |
| 147 | 2924765-23-9 | RXFP1 receptor agonist-9 | | | | |
| 148 | 2924767-53-1 | RXFP1 receptor agonist-3 | C42H34F9N3O5 | 831.72 | | |
| 149 | 2924771-07-1 | 1H-Indole-2,3-dione, 7-methoxy-1-octyl- (ACI) | | | | |
| 150 | 29248-48-4 | Boc-Gly-Gly-OSu | C13H19N3O7 | 329.31 | | |
| 151 | 29248-55-3 | Hydrazine,(1-phenylethyl)-, hydrochloride (1:1) | C8H13ClN2 | 172.66 | | |
| 152 | 2924808-29-5 | Felmetatug | | | | |
| 153 | 2924817-35-4 | Flucloxacillin EP Impurity A Sodium Salt(Mixture of Diastereomers) | | | | |
| 154 | 2924817-37-6 | Flucloxacillin EP Impurity E | C27H27ClFN5O7S2 | 652.12 | | |
| 155 | 2924824-02-0 | (R)-1-(2,3-Dihydrobenzofuran-5-yl)propan-1-amine hydrochloride | C11H15NO.ClH | 213.7 | | |
| 156 | 2924824-03-1 | Neuropeptide SF (human) (acetate) | C67H98N18O17 | 1427.61 | | |
| 157 | 2924824-04-2 | Desthiobiotin-Iodoacetamide | C14H25IN4O3 | 424.28 | | |
| 158 | 2924824-08-6 | Cis-2-benzyl-3a-methyl-octahydropyrrolo[3,4-c]pyrrole hydrochloride | | | | |
| 159 | 2924824-32-6 | 2-(4-((Benzyloxy)carbonyl)-1,4-diazepan-1-yl)acetic acid hydrochloride | C15H20N2O4.ClH | 328.79 | | |
| 160 | 2924824-34-8 | 3-Amino-N-cyclopropylcyclohexanecarboxamide hydrochloride | | 218.72 | | |
| 161 | 2924824-43-9 | AKR1C3-IN-9 | C20H20N2O4 | 352.38 | | |
| 162 | 2924824-48-4 | AchE/BCHE-IN-10 | C26H30N2O2 | 402.53 | | |
| 163 | 2924824-55-3 | sodium salt | C7H4ClN3O2.Na | 220.57 | | |
| 164 | 2924824-56-4 | ARUK2001607 | C14H13N3O2S2 | 319.4 | | |
| 165 | 2924824-58-6 | 3-(4-Bromo-2-chlorophenoxy)azetidine hydrochloride | C9H9BrClNO.ClH | 298.99 | | |
| 166 | 2924824-59-7 | 1,3-Dimethyl-6-oxo-1h,6h,7h-pyrazolo[3,4-b]pyridine-4-carboxylic acid (trihydrochloride) | | | | |
| 167 | 2924825-23-8 | Pyrido[2,3-d]pyrimidine-2,4(1H,3H)-dione, 1-[4-(difluoromethoxy)phenyl]-7-ethoxy-3-(1,2,3,4-tetrahydro-2-methylpyrazino[1,2-a]benzimidazol-7-yl)- | C27H24F2N6O4 | 534.52 | | |
| 168 | 2924827-60-9 | 1,3-Dioxane-4-acetamide, 6-(2-aminoethyl)-2,2-dimethyl-, (4R,6R)- | C10H20N2O3 | 216.28 | | |
| 169 | 2924835-36-7 | Pomalidomide-amino-PEG4-C4-Cl | C27H36ClN3O9 | 582.04 | | |
| 170 | 2924835-48-1 | Zipalertinib Impurity 25 | | | | |
| 171 | 2924835-50-5 | Zipalertinib Impurity 24 | | | | |
| 172 | 2924835-55-0 | 1H-Benzimidazole, 6-methoxy-1-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]thio]- | C26H30N4O3S | 478.61 | | |
| 173 | 2924841-75-6 | Muvalaplin Impurity 5 | | | | |
| 174 | 2924841-79-0 | (2S)-3-(3-{[(2-{3-[(2S)-2-carboxy-2-[(3R)-pyrrolidin-3-yl]ethyl]phenoxy}ethyl)({3-[(2S)-2-carboxy-2-[(3R)-pyrrolidin-3-yl]ethyl]phenyl}methyl)amino]methyl}phenyl)-2-[(3R)-pyrrolidin-3-yl]propanoic acid | C43H56N4O7 | 740.93 | | |
| 175 | 2924841-80-3 | Lp(a)-IN-5 hydrochloride | | | | |
| 176 | 2924842-16-8 | 3-Pyrrolidineacetic acid, α-[[3-(2-aminoethoxy)phenyl]methyl]-1-[(1,1-dimethylethoxy)carbonyl]-, 1,1-dimethylethyl ester, (αS,3R)- | C24H38N2O5 | 434.57 | | |
| 177 | 2924858-25-1 | 2-(2,6-dioxopiperidin-3-yl)-5-morpholinoisoindoline-1,3-dione | C17H17N3O5 | 343.33 | | |
| 178 | 2924858-26-2 | 1H-Isoindole-1,3(2H)-dione, 5-(cyclohexylamino)-2-(2,6-dioxo-3-piperidinyl)- | C19H21N3O4 | 355.39 | | |
| 179 | 2924858-30-8 | Thalidomide-N-methylpiperazine | C18H20N4O4 | 356.38 | | |
| 180 | 2924858-38-6 | Thalidomide-piperidine | C18H19N3O4 | 341.36 | | |
| 181 | 2924858-40-0 | 1H-Isoindole-1,3(2H)-dione, 4-(cyclohexylamino)-2-(2,6-dioxo-3-piperidinyl)- | C19H21N3O4 | 355.39 | | |
| 182 | 2924872-84-2 | DBCO-PEG24-Maleimide | C76H122N4O29 | 1555.79 | | |
| 183 | 2924883-83-8 | DPP-21 | C17H16N4S | 308.4 | | |
| 184 | 29249-00-1 | Phenol,4-(2-aminoethyl)methoxy- | C9H13NO2 | | | |
| 185 | 29249-55-6 | 2-Undecylimidazoline | C14H28N2 | 224.39 | 82℃ | |
| 186 | 29249-66-9 | Benzene, 1,1'-(1,2-ethanediyl)bis(dimethyl- | C18H24 | 240.38316 | | |
| 187 | 2924909-11-3 | NA | | | | |